Corticotropin-releasing hormone neurons control trigeminal neuralgia-induced anxiodepression via a hippocampus-to-prefrontal circuit.
Su-Su LvXue-Jing LvYa-Qi CaiXin-Yu HouZhi-Zhe ZhangGuo-Hong WangLi-Qiang ChenNing LüYu-Qiu ZhangPublished in: Science advances (2024)
Anxiety and depression are frequently observed in patients suffering from trigeminal neuralgia (TN), but neural circuits and mechanisms underlying this association are poorly understood. Here, we identified a dedicated neural circuit from the ventral hippocampus (vHPC) to the medial prefrontal cortex (mPFC) that mediates TN-related anxiodepression. We found that TN caused an increase in excitatory synaptic transmission from vHPC CaMK2A neurons to mPFC inhibitory neurons marked by the expression of corticotropin-releasing hormone (CRH). Activation of CRH + neurons subsequently led to feed-forward inhibition of layer V pyramidal neurons in the mPFC via activation of the CRH receptor 1 (CRHR1). Inhibition of the vHPC CaMK2A -mPFC CRH circuit ameliorated TN-induced anxiodepression, whereas activating this pathway sufficiently produced anxiodepressive-like behaviors. Thus, our studies identified a neural pathway driving pain-related anxiodepression and a molecular target for treating pain-related psychiatric disorders.
Keyphrases
- prefrontal cortex
- spinal cord
- neuropathic pain
- end stage renal disease
- chronic pain
- diabetic rats
- high glucose
- chronic kidney disease
- drug induced
- spinal cord injury
- pain management
- poor prognosis
- oxidative stress
- peritoneal dialysis
- working memory
- functional connectivity
- patient reported outcomes
- long non coding rna
- cerebral ischemia
- high frequency